Bell Investment Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-84
Closed -$8.53K 1887
2025
Q4
$8.53K Buy
84
+5
+6% +$402 ﹤0.01% 750
2025
Q3
$4.32K Sell
79
-12
-13% -$600 ﹤0.01% 996
2025
Q2
$4.84K Buy
91
+36
+65% +$1.83K ﹤0.01% 991
2025
Q1
$2.38K Sell
55
-21
-28% -$1.06K ﹤0.01% 1244
2024
Q4
$4.27K Buy
76
+9
+13% +$560 ﹤0.01% 994
2024
Q3
$4.57K Buy
67
+1
+2% +$56 ﹤0.01% 979
2024
Q2
$2.79K Buy
66
+8
+14% +$440 ﹤0.01% 1215
2024
Q1
$4.01K Sell
58
-8
-12% -$506 ﹤0.01% 1041
2023
Q4
$4.88K Hold
66
﹤0.01% 898
2023
Q3
$4.5K Sell
66
-16
-20% -$1.36K ﹤0.01% 865
2023
Q2
$7.7K Buy
82
+13
+19% +$1.01K ﹤0.01% 615
2023
Q1
$4.68K Hold
69
﹤0.01% 824
2022
Q4
$3.42K Sell
69
-8
-10% -$327 ﹤0.01% 1004
2022
Q3
$3K Buy
77
+54
+235% +$2.23K ﹤0.01% 899
2022
Q2
$1K Buy
+23
New +$1.23K ﹤0.01% 1426
2021
Q4
$4K Buy
55
+3
+6% +$265 ﹤0.01% 854
2021
Q3
$5K Buy
+52
New +$5.49K ﹤0.01% 701

Other funds holding EXAS

Bell Investment Advisors's EXAS Position: Q1 2026 in Review

Bell Investment Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 84 shares — an estimated $8.53K sold.

Bell Investment Advisors first reported a position in EXAS in Q3 2021 and held it in 17 quarters. The position peaked at $8.53K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bell Investment Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bell Investment Advisors sold 84 Exact Sciences shares in Q1 2026, an estimated $8.53K.
  • Bell Investment Advisors first reported a position in Exact Sciences in Q3 2021 and held it in 17 quarters.
  • Bell Investment Advisors's Exact Sciences position peaked at $8.53K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.